| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GPL16384
|
CEL
|
|||||||
| GSM3554020 |
KYSE-30, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554021 |
KYSE-30, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554022 |
KYSE-30R, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554023 |
KYSE-30R, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554024 |
KYSE-70, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554025 |
KYSE-70, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554026 |
KYSE-70R, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554027 |
KYSE-70R, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554028 |
KYSE-180, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554029 |
KYSE-180, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554030 |
KYSE-180R, biological rep1
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM3554031 |
KYSE-180R, biological rep2
|
RNA | 1 |
|
|
Aiping Luo | Jan 01, 2025 | ||
| GSM2909394 |
Non-tumor adult A2B5+ WM, sample 1
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909395 |
Non-tumor adult A2B5+ WM, sample 2
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909396 |
Non-tumor adult A2B5+ WM, sample 3
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909397 |
Non-tumor adult A2B5+ WM, sample 4
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909398 |
Non-tumor fetal CD140a+ CTX, sample 1
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909399 |
Non-tumor fetal CD140a+ CTX, sample 2
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909400 |
Non-tumor fetal CD140a+ CTX, sample 3
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 | ||
| GSM2909401 |
Non-tumor fetal CD140a+ CTX, sample 4
|
RNA | 1 |
|
|
Steven Goldman | Feb 12, 2024 |
